Seetha Harilal

883 total citations
20 papers, 655 citations indexed

About

Seetha Harilal is a scholar working on Infectious Diseases, Surgery and Molecular Biology. According to data from OpenAlex, Seetha Harilal has authored 20 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Seetha Harilal's work include SARS-CoV-2 and COVID-19 Research (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Alzheimer's disease research and treatments (2 papers). Seetha Harilal is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Alzheimer's disease research and treatments (2 papers). Seetha Harilal collaborates with scholars based in India, Saudi Arabia and Bangladesh. Seetha Harilal's co-authors include Bijo Mathew, Rajesh Kumar, Della Grace Thomas Parambi, Githa Elizabeth Mathew, Jobin Jose, Md. Sahab Uddin, Lotfi Aleya, Hoon Kim, Hoon Kim and Simone Carradori and has published in prestigious journals such as Environmental Science and Pollution Research, European Journal of Medicinal Chemistry and Current Medicinal Chemistry.

In The Last Decade

Seetha Harilal

19 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seetha Harilal India 11 170 157 153 103 83 20 655
Zhibing Wu China 18 304 1.8× 326 2.1× 148 1.0× 118 1.1× 76 0.9× 65 960
Shadabul Haque Australia 15 349 2.1× 160 1.0× 273 1.8× 94 0.9× 56 0.7× 22 1.1k
Nallupillai Paramakrishnan India 9 140 0.8× 108 0.7× 231 1.5× 126 1.2× 57 0.7× 19 596
Xinrui Li China 16 320 1.9× 142 0.9× 117 0.8× 61 0.6× 92 1.1× 55 767
Lei Peng China 16 341 2.0× 132 0.8× 202 1.3× 65 0.6× 54 0.7× 40 906
Amira Sayed Hanafy Egypt 10 164 1.0× 75 0.5× 124 0.8× 137 1.3× 54 0.7× 18 596
Mohammad Fazil India 19 436 2.6× 152 1.0× 296 1.9× 98 1.0× 75 0.9× 21 1.4k
Thilini Thrimawithana Australia 15 310 1.8× 82 0.5× 109 0.7× 65 0.6× 41 0.5× 43 1.2k
Rui Xue China 15 227 1.3× 123 0.8× 82 0.5× 192 1.9× 36 0.4× 54 637

Countries citing papers authored by Seetha Harilal

Since Specialization
Citations

This map shows the geographic impact of Seetha Harilal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seetha Harilal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seetha Harilal more than expected).

Fields of papers citing papers by Seetha Harilal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seetha Harilal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seetha Harilal. The network helps show where Seetha Harilal may publish in the future.

Co-authorship network of co-authors of Seetha Harilal

This figure shows the co-authorship network connecting the top 25 collaborators of Seetha Harilal. A scholar is included among the top collaborators of Seetha Harilal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seetha Harilal. Seetha Harilal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Rajesh, et al.. (2025). Nanotechnology-enhanced phytomedicines: Innovations and applications in cancer therapy. International Immunopharmacology. 166. 115537–115537. 1 indexed citations
2.
Kumar, Rajesh, et al.. (2024). Rosa canina and Cancer: Which Evidence?. Journal of Herbal Medicine. 45. 100875–100875. 1 indexed citations
3.
Mishra, Abhay Prakash, Rajesh Kumar, Seetha Harilal, et al.. (2024). Demystifying the management of cancer through smart nano-biomedicine via regulation of reactive oxygen species. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(1). 497–532. 6 indexed citations
4.
Mishra, Abhay Prakash, et al.. (2024). Emerging Landscape of In Vitro Models for Assessing Rheumatoid Arthritis Management. ACS Pharmacology & Translational Science. 7(8). 2280–2305. 2 indexed citations
5.
Kumar, Rajesh, Seetha Harilal, Mohamed A. Abdelgawad, et al.. (2023). Urachal carcinoma: The journey so far and the road ahead. Pathology - Research and Practice. 243. 154379–154379. 9 indexed citations
6.
Kumar, Rajesh, Seetha Harilal, Abdullah G. Al‐Sehemi, et al.. (2022). Advancements in COVID-19 Testing: An In-depth Overview. Current Pharmaceutical Biotechnology. 24(9). 1122–1148. 1 indexed citations
7.
Parambi, Della Grace Thomas, Khalid Saad Alharbi, Rajesh Kumar, et al.. (2021). Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases. Molecular Neurobiology. 59(1). 191–233. 45 indexed citations
8.
Mathew, Bijo, et al.. (2021). Current Perspective of COVID-19 on Neurology: A Mechanistic Insight. Combinatorial Chemistry & High Throughput Screening. 25(5). 763–767. 6 indexed citations
9.
Kumar, Rajesh, Seetha Harilal, Della Grace Thomas Parambi, et al.. (2021). The Role of Mitochondrial Genes in Neurodegenerative Disorders. Current Neuropharmacology. 20(5). 824–835. 9 indexed citations
10.
Kumar, Rajesh, Seetha Harilal, Abdullah G. Al‐Sehemi, et al.. (2020). COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2. Current Pharmaceutical Design. 27(9). 1194–1201. 14 indexed citations
11.
Harilal, Seetha, Jobin Jose, Della Grace Thomas Parambi, et al.. (2020). Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules. Brain Research Bulletin. 160. 121–140. 89 indexed citations
12.
Harilal, Seetha, et al.. (2020). Molecular mechanism of zinc neurotoxicity in Alzheimer’s disease. Environmental Science and Pollution Research. 27(35). 43542–43552. 40 indexed citations
13.
Parambi, Della Grace Thomas, Uzma Saleem, Muhammad Ajmal Shah, et al.. (2020). Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson’s Disease. Neurochemical Research. 45(11). 2786–2799. 25 indexed citations
14.
Mathew, Bijo, Seetha Harilal, Arafa Musa, et al.. (2020). An Agathokakological Tale of Δ9-THC: Exploration of Possible Biological Targets. Current Drug Targets. 22(7). 823–834. 2 indexed citations
15.
Kumar, Rajesh, Seetha Harilal, Simone Carradori, & Bijo Mathew. (2020). A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century. Current Medicinal Chemistry. 28(14). 2657–2696. 30 indexed citations
16.
Kumar, Rajesh, Seetha Harilal, Abdullah G. Al‐Sehemi, et al.. (2020). The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic. Current Medicinal Chemistry. 28(15). 2852–2886. 22 indexed citations
17.
Kumar, Rajesh, Seetha Harilal, Della Grace Thomas Parambi, et al.. (2020). Fascinating Chemopreventive Story of Wogonin: A Chance to Hit on the Head in Cancer Treatment. Current Pharmaceutical Design. 27(4). 467–478. 12 indexed citations
18.
Kumar, Rajesh, Seetha Harilal, Sheeba Varghese Gupta, et al.. (2019). Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work. European Journal of Medicinal Chemistry. 182. 111602–111602. 46 indexed citations
19.
Jose, Jobin, Rajesh Kumar, Seetha Harilal, et al.. (2019). Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool. Environmental Science and Pollution Research. 27(16). 19214–19225. 177 indexed citations
20.
Harilal, Seetha, Jobin Jose, Della Grace Thomas Parambi, et al.. (2019). Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives. Journal of Pharmacy and Pharmacology. 71(9). 1370–1383. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhibing Wu Breakdown of academic impact, for papers by Shadabul Haque Breakdown of academic impact, for papers by Nallupillai Paramakrishnan Breakdown of academic impact, for papers by Xinrui Li Breakdown of academic impact, for papers by Lei Peng Breakdown of academic impact, for papers by Amira Sayed Hanafy Breakdown of academic impact, for papers by Mohammad Fazil Breakdown of academic impact, for papers by Thilini Thrimawithana Breakdown of academic impact, for papers by Rui Xue
Rankless by CCL
2026